REPORT ID 6921

United States Endocrine System Drug Market Report 2017

Publish Date
1-Nov-17
Pages
95
Format
Electronic (PDF)

In this report, the United States Endocrine System Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Endocrine System Drug in these regions, from 2012 to 2022 (forecast).

United States Endocrine System Drug market competition by top manufacturers/players, with Endocrine System Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Novo Nordisk
    Sanofi
    Merck
    Eli Lilly
    AstraZeneca
    AbbVie
    ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Diabetes Drug
    Human Growth Hormones
    Thyroid Hormone Disorder Drugs
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinic
    Medical Center
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Endocrine System Drug Market Report 2017
1 Endocrine System Drug Overview
    1.1 Product Overview and Scope of Endocrine System Drug
    1.2 Classification of Endocrine System Drug by Product Category
        1.2.1 United States Endocrine System Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Endocrine System Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Diabetes Drug
        1.2.4 Human Growth Hormones
        1.2.5 Thyroid Hormone Disorder Drugs
        1.2.6 Others
    1.3 United States Endocrine System Drug Market by Application/End Users
        1.3.1 United States Endocrine System Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Medical Center
        1.3.5 Others
    1.4 United States Endocrine System Drug Market by Region
        1.4.1 United States Endocrine System Drug Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Endocrine System Drug Status and Prospect (2012-2022)
        1.4.3 Southwest Endocrine System Drug Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Endocrine System Drug Status and Prospect (2012-2022)
        1.4.5 New England Endocrine System Drug Status and Prospect (2012-2022)
        1.4.6 The South Endocrine System Drug Status and Prospect (2012-2022)
        1.4.7 The Midwest Endocrine System Drug Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Endocrine System Drug (2012-2022)
        1.5.1 United States Endocrine System Drug Sales and Growth Rate (2012-2022)
        1.5.2 United States Endocrine System Drug Revenue and Growth Rate (2012-2022)

2 United States Endocrine System Drug Market Competition by Players/Suppliers
    2.1 United States Endocrine System Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Endocrine System Drug Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Endocrine System Drug Average Price by Players/Suppliers (2012-2017)
    2.4 United States Endocrine System Drug Market Competitive Situation and Trends
        2.4.1 United States Endocrine System Drug Market Concentration Rate
        2.4.2 United States Endocrine System Drug Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Endocrine System Drug Manufacturing Base Distribution, Sales Area, Product Type

3 United States Endocrine System Drug Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Endocrine System Drug Sales and Market Share by Region (2012-2017)
    3.2 United States Endocrine System Drug Revenue and Market Share by Region (2012-2017)
    3.3 United States Endocrine System Drug Price by Region (2012-2017)

4 United States Endocrine System Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Endocrine System Drug Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Endocrine System Drug Revenue and Market Share by Type (2012-2017)
    4.3 United States Endocrine System Drug Price by Type (2012-2017)
    4.4 United States Endocrine System Drug Sales Growth Rate by Type (2012-2017)

5 United States Endocrine System Drug Sales (Volume) by Application (2012-2017)
    5.1 United States Endocrine System Drug Sales and Market Share by Application (2012-2017)
    5.2 United States Endocrine System Drug Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Endocrine System Drug Players/Suppliers Profiles and Sales Data
    6.1 Novo Nordisk
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Endocrine System Drug Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Novo Nordisk Endocrine System Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Sanofi
        6.2.2 Endocrine System Drug Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Sanofi Endocrine System Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Merck
        6.3.2 Endocrine System Drug Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Merck Endocrine System Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Eli Lilly
        6.4.2 Endocrine System Drug Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Eli Lilly Endocrine System Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 AstraZeneca
        6.5.2 Endocrine System Drug Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 AstraZeneca Endocrine System Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 AbbVie
        6.6.2 Endocrine System Drug Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 AbbVie Endocrine System Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    ...

7 Endocrine System Drug Manufacturing Cost Analysis
    7.1 Endocrine System Drug Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Endocrine System Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Endocrine System Drug Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Endocrine System Drug Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Endocrine System Drug Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Endocrine System Drug Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Endocrine System Drug Sales Volume Forecast by Type (2017-2022)
    11.3 United States Endocrine System Drug Sales Volume Forecast by Application (2017-2022)
    11.4 United States Endocrine System Drug Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer